title: Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study.
abstract: OBJECTIVE
  The purpose of the present study was to collect data from population-based cancer registries and to calculate relative 5-year survival of cancer patients in Japan. We also sought to determine time trends and to compare the results with international studies.
  
  
  METHODS
  We asked 11 population-based cancer registries to submit individual data for patients diagnosed from 1993 to 1999, together with data on outcome after 5 years. Although all these registries submitted data (491 772 cases), only six met the required standards for the quality of registration data and follow-up investigation. The relative 5-year survival calculated by pooling data from 151 061 cases from six registries was taken as the survival for cancer patients in Japan.
  
  
  RESULTS
  Relative 5-year survival (1997-99) was 54.3% for all cancers (males: 50.0%, females: 59.8%). Survival figures for all sites changed slightly over the 7-year period, from 53.2% for the first 4 years of the study (1993-96) to 54.3% for the last 3 years (1997-99), however, a major improvement was observed in several primary sites. Some overall survival was lower in Japan than in the USA, but similar to that in European countries. Specifically, survival for uterine cancer, prostate cancer, testis cancer, lymphoma and leukemia was much lower in Japan than in other countries. However, survival was better in Japan mainly for cancers of the esophagus, stomach, colon, liver and gallbladder.
  
  
  CONCLUSIONS
  The study suggests an improvement in cancer survival in several primary sites in Japan, which is consistent with the development of treatments and early detection.
authors.affiliation: Population-Based Cancer Registry Section, Cancer Information Services and Surveillance Division, Center for Cancer Control and Information Services, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. tomatsud@ncc.go.jp
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Matsuda
authors.forename: Wakiko
authors.initials: W
authors.lastname: Ajiki
authors.forename: Tomomi
authors.initials: T
authors.lastname: Marugame
authors.forename: Akiko
authors.initials: A
authors.lastname: Ioka
authors.forename: Hideaki
authors.initials: H
authors.lastname: Tsukuma
authors.forename: Tomotaka
authors.initials: T
authors.lastname: Sobue
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D015986:Confounding Factors, Epidemiologic; D004067:Digestive System Neoplasms / Q000401:mortality; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D007938:Leukemia / Q000401:mortality; D008207:Lymphatic Metastasis; D008223:Lymphoma / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000175:diagnosis* / Q000401:mortality* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000401:mortality; D012042:Registries; D017678:Sex Distribution; D016019:Survival Analysis; D015996:Survival Rate; D013736:Testicular Neoplasms / Q000401:mortality; D014481:United States / Q000453:epidemiology; D014594:Uterine Neoplasms / Q000401:mortality